| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172879 Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity |
| 02/06/2007 | US7172875 Identifying inhibitors of intracellular protein fibrillization |
| 02/06/2007 | US7172870 Treatment of papillomavirus infections |
| 02/06/2007 | US7172867 Methods of testing for allergic diseases, and therapeutic agents for treating same |
| 02/06/2007 | US7172773 Fish oil, peppermint oil, and lipase; human diet; health |
| 02/06/2007 | US7172768 Storage stable powder compositions of interleukin-4 receptor |
| 02/06/2007 | US7172764 Rescue agents for treating botulinum toxin intoxications |
| 02/06/2007 | US7172763 Post-operative pain treatment by peripheral administration of a neurotoxin |
| 02/06/2007 | US7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/06/2007 | US7172759 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 02/06/2007 | US7172757 Method of treating fibroproliferative disorders |
| 02/06/2007 | US7172756 Methods of promoting tolerogenic immune responses and compositions therefor |
| 02/06/2007 | US7172755 Process control; metastasis; polypeptides |
| 02/06/2007 | US7172751 D-amino acid peptides |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | US7172629 Osteogenic paste compositions and uses thereof |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2297297C Blood product delivery system |
| 02/06/2007 | CA2286903C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
| 02/06/2007 | CA2274146C Genetic modification of primate hemopoietic repopulating stem cells |
| 02/06/2007 | CA2166479C Density enhanced protein tyrosine phosphatases |
| 02/06/2007 | CA2132507C Method for altering hair growth and compositions used therefore |
| 02/03/2007 | CA2555410A1 Compositions and methods for enhancing immunity by chemoattractant adjuvants |
| 02/01/2007 | WO2007014391A2 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 02/01/2007 | WO2007014372A2 Compositions and methods for treating bacteria |
| 02/01/2007 | WO2007014347A2 Method of treating a condition associated with phosphorylation of task-1 |
| 02/01/2007 | WO2007014327A2 Small compounds that correct protein misfolding and uses thereof |
| 02/01/2007 | WO2007014323A2 Use of heat shock to treat ocular disease |
| 02/01/2007 | WO2007014193A2 Peptidyl diacylglycerides |
| 02/01/2007 | WO2007014156A2 Fibroblast growth factor-2 promotes neurogenesis and neuroprotection and prolongs survival in huntington's disease |
| 02/01/2007 | WO2007014073A2 Concentrated protein lyophilates, methods, and uses |
| 02/01/2007 | WO2007014051A2 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 02/01/2007 | WO2007013852A1 Modulators |
| 02/01/2007 | WO2007013807A2 Targeting-enhanced activation of galectins |
| 02/01/2007 | WO2007013677A1 Potentiator for substance having interferon-like effect |
| 02/01/2007 | WO2007013603A1 Lymphangiogenesis promoter |
| 02/01/2007 | WO2007013593A1 Method for diagnosis of gastric cancer utilizing methylation of novel gene acmg1 as index |
| 02/01/2007 | WO2007013586A1 Novel peptide |
| 02/01/2007 | WO2007013574A1 Compositions and methods for treating breast cancer |
| 02/01/2007 | WO2007013487A1 Method of producing bulk colistin powder |
| 02/01/2007 | WO2007013452A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium |
| 02/01/2007 | WO2007013438A1 Anti-obesity agent and anti-obesity food |
| 02/01/2007 | WO2007013426A1 Process for production of fermented milk and fermented milk beverage/food |
| 02/01/2007 | WO2007013358A2 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 02/01/2007 | WO2007013352A1 Medicinal composition containing hla-a24 molecule-binding peptide originating in parathyroid hormone-related protein |
| 02/01/2007 | WO2007013147A1 Angiogenesis inhibitor and vascular regressive agent |
| 02/01/2007 | WO2007013100A1 Gel formulation comprising platelet derived growth factor |
| 02/01/2007 | WO2007013050A1 Heparanase-derived peptide dimers and their uses as inhibitors of heparanase |
| 02/01/2007 | WO2007012970A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 02/01/2007 | WO2007012944A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 02/01/2007 | WO2007012876A1 Hydrogel particle |
| 02/01/2007 | WO2007012764A2 Cell/ligand marking system, wherein the marker is of eph type, cell material comprising said system, method for preparing same and proangiogenetic use |
| 02/01/2007 | WO2007012748A2 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 02/01/2007 | WO2007012430A1 Method for induction and enhancement of apoptosis in tumor cells |
| 02/01/2007 | WO2007012277A1 Isolated proteins from a traditional chinese medicine yuzhu and use thereof |
| 02/01/2007 | WO2007012191A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | WO2007012117A1 Compositions and methods for culturing embryos and oocytes |
| 02/01/2007 | WO2006132530A3 Methods and means for use in diagnostics and treatment of diabetes |
| 02/01/2007 | WO2006131586B1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/01/2007 | WO2006125962A3 T cell receptors which specifically bind to vygfvracl-hla-a24 |
| 02/01/2007 | WO2006119527A8 Melanoma-associated endogenous retrovirus (merv) derived peptide sequences and their therapeutic/ diagnostic use |
| 02/01/2007 | WO2006118617A3 EXPRESSING TGF-β PROTEINS IN PLANT PLASTIDS |
| 02/01/2007 | WO2006105374A3 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| 02/01/2007 | WO2006105345A3 Compositions and methods for the control, prevention, and treatment of obesity and eating disorders |
| 02/01/2007 | WO2006104852A3 Vegf antagonist formulations |
| 02/01/2007 | WO2006102069A3 Methods and compositions for the treatment of hypertension and gastrointestinal disorders |
| 02/01/2007 | WO2006099006A3 Recombinant e-selectin made in insect cells |
| 02/01/2007 | WO2006091517A3 Immunogens from uropathogenic escherichia coli |
| 02/01/2007 | WO2006091229A3 Methods of modulating intracellular degradation rates of toxins |
| 02/01/2007 | WO2006088473A3 Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| 02/01/2007 | WO2006078746A3 Method, compositions and classification for tumor diagnostics and treatment |
| 02/01/2007 | WO2006073734A3 Modulator of alpha-synuclein toxicity |
| 02/01/2007 | WO2006066024A3 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 02/01/2007 | WO2006034106A3 Baff variants and methods therof |
| 02/01/2007 | WO2006029094A3 Erythropoietin derivatives with altered immunogenicity |
| 02/01/2007 | WO2006012644A3 Use of il-28 and il-29 to treat cancer |
| 02/01/2007 | WO2006004868A3 Bioactive peptide coatings |
| 02/01/2007 | WO2005105837A3 Use of the ribosomal protein rpl41 to treat infections and inhibit cancer |
| 02/01/2007 | WO2005081816A3 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants |
| 02/01/2007 | WO2005069854A3 Methods and materials relating to novel c1q domain-containing polypeptides and polynucleotides |
| 02/01/2007 | WO2005062959A3 Isolated t lymphocyte receptors specific for human autoantigens complexed with human mhc molecules and methods of making and using same |
| 02/01/2007 | WO2005058332A3 Edestin-comprising agent for substitution of blood plasma and a method of its production |
| 02/01/2007 | WO2004058088A8 Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries |
| 02/01/2007 | WO2004003005A3 Sh2 domain binding inhibitors |
| 02/01/2007 | WO2003105773A3 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: |
| 02/01/2007 | WO2003058203A3 Extended glucagon-like peptide-1 analogs |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070028314 Bone and/or joint disease-associated genes |
| 02/01/2007 | US20070028311 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15 |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027102 Methods and compositions for treating macular degeneration |
| 02/01/2007 | US20070027098 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 02/01/2007 | US20070027091 Therapy of obesity, diabetes, bulimia, atherosclerosis, hypertension, diabetes, type 2 diabetes, impaired glucose tolerance (IGT), dyspilidemia, coronary heart disease, gallbladder disease, gall stone, osteoarthritis, cancer, sexual dysfunction, and the risk of premature death; cyclic peptides |
| 02/01/2007 | US20070027090 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 02/01/2007 | US20070027089 Inhibitors of amyloid precursor protein processing |
| 02/01/2007 | US20070027088 Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock |
| 02/01/2007 | US20070027087 Methods for preventing mitochondrial permeability transition |
| 02/01/2007 | US20070027086 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as antiinflammatory and immunomodulatory agent; inhibit the production of nitric oxide (NO) |
| 02/01/2007 | US20070027085 Microencapsulation and sustained release of biologically active polypeptides |